Video

Hep C: Public Health Achievement Requires Immediate Application of Interventions

Author(s):

We've had a 150% increase in the number of new cases of hepatitis C in the country, and almost all of those cases are among persons less than 30 years of age," John W. Ward, MD, of CDC said.

John W. Ward, MD, from the CDC said that his team has been working with the Institute of Medicine to "lay out the blueprint" for what's necessary to eliminate hepatitis C in the country. "We have the drugs that can prevent the liver disease, the liver cancer that kills people with hepatitis c, and we have interventions that can interrupt transmission. So, let's put all those together and truly eliminate this from the country," Ward said.

Ward continued to explain that some states, like New York, have already gotten the message about how hepatitis C can be eliminated and are already taking action of their own while they wait for national reporting. They’re bringing together clinicians, health system experts, policy makers, and community organizations to really develop a community-based approach to elimination.

At CROI 2017, Ward shared with MD Magazine, that researchers need to turn their attention toward the rising number of young people becoming infected with hepatitis C. "We have an opioid crises around the world, meaning many young people began using opioids and inject themselves, leading to transmission among people who are sharing that injection equipment. We've had a 150% increase in the number of new cases of hepatitis C in the country, and almost all of those cases are among persons less than 30 years of age," Ward concluded.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.